Global Digital PCR (d-PCR) Market: Focus on Product-Type, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025

"Global Digital Polymerase Chain Reaction (d-PCR) Market to Reach $585.8 million by 2025."

Market Report Coverage - Digital PCR (d-PCR)

Market Segmentation

• Product Type - Assays and Reagents, Platforms, Accessories, and Instruments

• Application- Clinical, Environmental Monitoring, Food and Agriculture and Others

• End User - Hospital and Clinics, Academic and Research Institutions, Diagnostic Centers, and Other End Users

Regional Segmentation

• North America - U.S., Canada

• Europe - Germany, France, Italy, U.K., Spain, and Rest-of-Europe

• Asia-Pacific - China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)

• Latin America - Brazil, Mexico, and Rest-of-the-Latin America

• Rest-of-the-World

Growth Drivers

• Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics

• Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders

• Significant External Funding for Executive R&D Exercises

Market Challenges

• Shortage of Skilled Professionals and Trained Lab-Technicians

• High Cost of Platforms Associated with Digital-PCR

Market Opportunities

• Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations

• Technological Advancements in the development of Digital PCR-based Solutions

• Increased Use of Digital PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan

Key Companies Profiled

Thermo Fisher Scientific, Bio-Rad Laboratories, Inc.., Optolane Technologies, Inc., Qiagen NV, Sysmex Corporation, SAGA Diagnostics AB, Stem Genomics, Fluidigm Corporation, Combinati, Merck KGaA, JN Medsys, Stilla Technologies, Dropworks, Inc. Naveris, Inc. Genetron Holdings Limited

Key Questions Answered in this Report:

• What are the major market drivers, challenges, and opportunities in the global digital PCR market?

• What is the potential impact of biotechnological advancement in diagnostic industry among the end users, such as researchers, physicians, and laboratory technicians?

• What is the current market demand along with future expected demand of global digital PCR market?

• How has digital PCR helped genomic tests to become a prominent tool for diagnostics in various clinical applications?

• What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?

• How each segment of the market is expected to grow during the forecast period from 2020 to 2025 based on:
  • Product Type
  • Clinical Area
  • End user
  • Region: Region includes North America, Europe, Asia-Pacific, Rest-of-the-World (ROW)?

• Who are the leading players with significant offerings to the global digital PCR (d-PCR) market? What is the expected market dominance for each of these leading players?

• Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

BIS Research healthcare experts have found digital PCR (d-PCR) market to be one of the most rapidly evolving markets and the global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025. The market is driven by certain factors, which include the rising incidence of infectious disease, such as recent pandemic COVID-19, inciting the development of high-throughput diagnostics, increasing adoption of personalized medicine for the screening and diagnostics of genetic disorders, and significant external funding for executing R&D exercises.

The market is favored by the development of digital PCR-based solutions for early diagnosis and rare mutation detection with absolute quantification of target sample. The gradual increase in the prevalence of infectious disease due to pandemic COVID-19 globally has furthered the digital PCR (d-PCR) market.

Furthermore, several diagnostic companies are focusing on the development of digital PCR diagnostics with higher sensitivity and low turn-around time to benefit the patients, enabling patient-based outcomes.

Within the research report, the market is segmented on the basis of product type, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of rapid diagnostics providing information on genetic mutation and patients good candidate for adjuvant chemotherapy or hormonal therapy. Due to the diverse product portfolio and intense market penetration, Bio-Rad Laboratories, Inc. has been a pioneer in this field and been a significant competitor in this market.

Several other companies, such as Qiagen NV, Sysmex Corporation., and Stilla Technlogies, among others, have launched technologically advanced digital PCR platforms, such as QIAcuity Digital PCR System, OncoBEAM digital PCR, and Naica System.

On the basis of region, North America holds the largest share of digital PCR (d-PCR) market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR of 18.11% during the forecast period.

Table of Contents

Executive Summary

1 Product Definition

• 1.1 Definition by Product
  • 1.1.1 Platforms
  • 1.1.2 Assays and Reagents
  • 1.1.3 Accessories and Instruments
• 1.2 Inclusion and Exclusion
• 1.3 Scope of Work
• 1.4 Key Questions Answered in the Report

2 Research Methodology

• 2.1 Primary Data Sources
• 2.2 Secondary Data Sources
• 2.3 Market Estimation Model
• 2.4 Criteria for Company Profiling

3 Market Overview

• 3.1 Digital PCR: A Next-Generation PCR Technology
• 3.2 Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
• 3.3 COVID-19 Impact on Digital PCR (d-PCR)
• 3.4 Digital PCR Clinical Trials

4 Global Digital PCR (d-PCR) Market Dynamics

• 4.1 Overview
• 4.2 Impact Analysis
• 4.3 Market Drivers
  • 4.3.1 Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics
  • 4.3.2 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
  • 4.3.3 Significant External Funding for Executing Research & Development Exercises
• 4.4 Market Restraints
  • 4.4.1 Shortage of Skilled Professionals and Trained Lab-Technicians
  • 4.4.2 High Cost of Platforms Associated with Digital-PCR
• 4.5 Market Opportunities
  • 4.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
  • 4.5.2 Technological Advancements in the Development of Digital-PCR Based Solutions
  • 4.5.3 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan

5 Competitive Landscape

• 5.1 Key Strategies and Developments
  • 5.1.1 Product Approvals
  • 5.1.2 Product Launches and Upgradations
  • 5.1.3 Synergistic Activities
  • 5.1.4 Funding and Expansion
  • 5.1.5 Mergers and Acquisitions
• 5.2 Patent Analysis
• 5.3 Market Share Analysis (by Company) 2019
• 5.4 Growth Share Analysis (Opportunity Mapping)
  • 5.4.1 By Company
• 5.5 Regulatory Framework
  • 5.5.1 Legal Requirements and Framework in the U.S.
  • 5.5.2 Legal Requirements and Framework in Europe
  • 5.5.3 Legal Requirements and Framework in Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan

6 Global Digital PCR (d-PCR) Market, by Product $Million, 2019-2025

• 6.1 Introduction
• 6.2 Assays and Reagents
• 6.3 Platforms
  • 6.3.1 Droplet-Based Digital PCR (d-PCR)
  • 6.3.2 Chip-Based Digital PCR (d-PCR)
• 6.4 Accessories and Instruments

7 Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025

• 7.1 Clinical
  • 7.1.1 Oncology
  • 7.1.2 Non-Oncology
    • 7.1.2.1 Infectious Disease
    • 7.1.2.2 Non-Invasive Prenatal Testing (NIPT)
    • 7.1.2.3 Forensics
• 7.2 Environmental Monitoring
• 7.3 Food and Agriculture
• 7.4 Other Applications

8 Digital PCR (d-PCR) Market (by End User), 2019-2025

• 8.1 Overview
• 8.2 Hospitals and Clinics
• 8.3 Academic and Research Institutions
• 8.4 Diagnostic Centers
• 8.5 Other End Users

9 Global Digital PCR (d-PCR) Market (by Region), 2019-2025

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest-of-Europe
• 9.4 Asia-Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Singapore
  • 9.4.6 Rest-of-APAC
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest-of-Latin America
• 9.6 Rest-of-the-World

10 Company Profiles

• 10.1 Overview
• 10.2 Bio-Rad Laboratories, Inc.
  • 10.2.1 Company Overview
  • 10.2.2 Role of Bio-Rad Laboratories, Inc. in Global Digital PCR Market
  • 10.2.3 Financials
  • 10.2.4 Key Insights About Financial Health of the Company
  • 10.2.5 SWOT Analysis
• 10.3 Combinati
  • 10.3.1 Company Overview
  • 10.3.2 Role of Combinati in Global Digital PCR Market
  • 10.3.3 SWOT Analysis
• 10.4 Dropworks, Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Role of Dropworks, Inc. in Global Digital PCR Market
• 10.5 Fluidigm Corporation
  • 10.5.1 Company Overview
  • 10.5.2 Role of Fluidigm Corporation in Global Digital PCR Market
  • 10.5.3 Financials
  • 10.5.4 Key Insights About Financial Health of the Company
  • 10.5.5 SWOT Analysis
• 10.6 Genetron Holdings Limited
  • 10.6.1 Company Overview
  • 10.6.2 Role of Genetron Holdings Limited in Global Digital PCR Market
  • 10.6.3 Financials
  • 10.6.4 Key Insights About Financial Health of the Company
  • 10.6.5 SWOT Analysis
• 10.7 JN Medsys
  • 10.7.1 Company Overview
  • 10.7.2 Role of JN Medsys in Global Digital PCR Market
  • 10.7.3 SWOT Analysis
• 10.8 Merck KGaA
  • 10.8.1 Company Overview
  • 10.8.2 Role of Merck KGaA in Global Digital PCR Market
  • 10.8.3 Financials
  • 10.8.4 Key Insights About Financial Health of the Company
  • 10.8.5 SWOT Analysis
• 10.9 Naveris, Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Role of Naveris, Inc. in Global Digital PCR Market
  • 10.9.3 SWOT Analysis
• 10.1 OPTOLANE Technologies Inc.
  • 10.10.1 Company Overview
  • 10.10.2 Role of OPTOLANE Technologies in Global Digital PCR Market
  • 10.10.3 SWOT Analysis
• 10.11 QIAGEN N.V.
  • 10.11.1 Company Overview
  • 10.11.2 Role of QIAGEN N.V. in Global Digital PCR Market
  • 10.11.3 Financials
  • 10.11.4 Key Insights About Financial Health of the Company
  • 10.11.5 SWOT Analysis
• 10.13 Saga Diagnostics AB
  • 10.13.1 Company Overview
  • 10.13.2 Role of Saga Diagnostics AB in Global Digital PCR Market
  • 10.13.3 SWOT Analysis
• 10.14 Stem Genomics
  • 10.14.1 Company Overview
  • 10.14.2 Role of Stem Genomics in Global Digital PCR Market
  • 10.14.3 SWOT Analysis
• 10.15 Sysmex Corporation
  • 10.15.1 Company Overview
  • 10.15.2 Role of Sysmex Corporation in Global Digital PCR Market
  • 10.15.3 Financials
  • 10.15.4 Key Insights About Financial Health of the Company
  • 10.15.5 SWOT Analysis
• 10.16 Stilla Technologies Inc.
  • 10.16.1 Company Overview
  • 10.16.2 Role of Stilla Technologies Inc. in Global Digital PCR Market
  • 10.16.3 SWOT Analysis
• 10.17 Thermo Fisher Scientific Inc.
  • 10.17.1 Company Overview
  • 10.17.2 Role of Thermo Fisher Scientific Inc. in Global Digital PCR Market
  • 10.17.3 Financials
  • 10.17.4 Key Insights About Financial Health of the Company
  • 10.17.5 SWOT Analysis

List of Tables

• Table 3.1: Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
• Table 3.2: Digital PCR (d-PCR) Diagnostics Solutions Offered for COVID-19
• Table 3.3: Digital PCR (d-PCR) Clinical Trials
• Table 4.1: Likert Scale
• Table 4.2: Impact Analysis of Market Drivers
• Table 4.3: Impact Analysis of Market Restraints
• Table 4.4: Funding Allocated for Precision Medicine to Different Agencies in U.S.
• Table 4.5: Funding for the Development of Digital PCR-based Diagnostics
• Table 4.6: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
• Table 5.1: Global Digital PCR (d-PCR) Patents 2016-2020
• Table 5.2: Classification Rules of IVDs Under the IVDR
• Table 5.3: Registration Criteria for IVD Medical Devices as per the CFDA
• Table 6.1: Market Available Digital PCR (d-PCR) Assay and Reagents
• Table 6.2: Market Available Digital PCR (d-PCR) Platforms
• Table 6.3: Market Available Digital PCR (d-PCR) Accessories and Instruments

List of Figures

• Figure 1: Total Global Disease Burden (by Cause), 2017
• Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Digital PCR (d-PCR) Market
• Figure 3: Global Digital PCR (d-PCR) Market (by Product Type) $Million, 2020 vs. 2025
• Figure 4: Global Digital-PCR (d-PCR) Market (by Application) $Million, 2020 vs. 2025
• Figure 5: Digital PCR (d-PCR) Market (by End User) $Million, 2020 vs. 2025
• Figure 6: Global Digital-PCR (d-PCR) Market Snapshot
• Figure 1.1: Global Digital-PCR (d-PCR) Market Segments
• Figure 2.1: Primary Research Methodology
• Figure 3.1: Working of Digital PCR
• Figure 3.2: Evolution of Digital PCR
• Figure 4.1: New Cases of Respiratory and Enteric Infections, Globally, 2012-2017
• Figure 4.2: Benefits of Multiplexing Infectious Disease Rapid Diagnostic Testing
• Figure 5.1: Share of Key Developments and Strategies, 2017-2020
• Figure 5.2: Product Launch and Upgradation Share (by Company), 2017-2020
• Figure 5.3: Synergistic Activities Share (by Company), 2017-2020
• Figure 5.4: Funding and Expansion Share (by Company), 2017-2020
• Figure 5.5: Market Share Analysis for the Global Digital PCR (d-PCR) Market, 2019
• Figure 5.6: Growth Share Matrix for Global Digital PCR (d-PCR) Market (by company), 2019
• Figure 5.7: Components Considered for Clinical Evidence as per the IVDR
• Figure 5.8: Process for Medical Device Designation by The MHLW and PDMA72
• Figure 6.1: Digital PCR (d-PCR) Market (by Product Type) $Million, 2019-2025
• Figure 6.2: Global Digital PCR (d-PCR) Market (Assays and Reagents) $Million, 2019-2025
• Figure 6.3: Digital PCR (d-PCR) Market (Platforms), 2019-2025 ($Millions)
• Figure 6.4: Digital PCR (d-PCR) Market (Droplet-Based), 2019-2025 ($Millions)
• Figure 6.5: Digital PCR (d-PCR) Market (Chip-Based), 2019-2025 ($Millions)
• Figure 6.6: Digital PCR (d-PCR) Market (Accessories and Instruments), 2019-2025 ($ Million)
• Figure 7.1: Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025
• Figure 7.2: Global Digital PCR (d-PCR) Market (by Clinical Application) $Million, 2019-2025
• Figure 7.3: Digital PCR (d-PCR) Market (Oncology) $Million, 2019-2025
• Figure 7.4: Digital PCR (d-PCR) Application Market (Non-Oncology) $Million, 2019-2025
• Figure 7.5: Digital PCR (d-PCR) Non-Oncology Market (by Type) $Million, 2019-2025
• Figure 7.6: Digital PCR (d-PCR) Market (by Infectious Disease) $Million, 2019-2025
• Figure 7.7: Digital PCR (d-PCR) Market (by NIPT) $Million, 2019-2025
• Figure 7.8: Digital PCR (d-PCR) Market (by Forensics) $Million, 2019-2025
• Figure 7.9: Digital PCR (d-PCR) Market (Environmental Monitoring) $Million, 2019-2025
• Figure 7.10: Digital PCR (d-PCR) Market (Food and Agriculture) $Million, 2019-2025
• Figure 7.11: Digital PCR (d-PCR) Market (Other Application) $Million, 2019-2025
• Figure 8.1: Global Digital PCR (d-PCR) Market $Million, by End User, 2019-2025
• Figure 8.2: Global Digital PCR (d-PCR) Market (Hospitals and Clinics) $Million, 2019-2025
• Figure 8.3: Global Digital PCR (d-PCR) Market (by Academic and Research Institutions), 2019-2025
• Figure 8.4: Global Digital PCR (d-PCR) Market (Diagnostic Centers) $Million, 2019-2025
• Figure 8.5: Global Digital PCR (d-PCR) Market (by Other End-User) $Million, 2019-2025
• Figure 9.1: Global Digital PCR (d-PCR) Market (by Region) $Million, 2020 and 2025
• Figure 9.2: Global Digital PCR (d-PCR) Market (by Region) $Million, 2019-2025
• Figure 9.3: North America: Market Dynamics
• Figure 9.4: North America Digital PCR (d-PCR) $Million, 2019-2025
• Figure 9.5: North America Digital PCR (d-PCR) (by Country) $Million, 2019-2025
• Figure 9.6: U.S. Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.7: Canada Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.8: Europe: Market Dynamics
• Figure 9.9: Europe Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.10: Europe Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
• Figure 9.11: Germany Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.12: U.K. Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.13: France Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.14: Italy Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.15: Spain Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.16: Rest-of-Europe Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.17: APAC: Market Dynamics
• Figure 9.18: Asia-Pacific Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.19: APAC Digital PCR (d-PCR) market (by Country) $Million, 2019-2025
• Figure 9.20: China Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.21: Japan Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.22: India Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.23: Australia Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.24: Singapore Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.25: RoAPAC Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 8.26: Latin America: Market Dynamics
• Figure 9.27: Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.28: Latin America Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
• Figure 9.29: Brazil Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.30: Mexico Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.31: Rest-of-Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 9.32: RoW Digital PCR (d-PCR) Market $Million, 2019-2025
• Figure 10.1: Total Number of Companies Profiled
• Figure 10.2: Bio-Rad Laboratories, Inc.: Product Portfolio
• Figure 10.3: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
• Figure 10.4: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
• Figure 10.5: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
• Figure 10.6: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
• Figure 10.7: Bio-Rad Laboratories, Inc.: SWOT Analysis
• Figure 10.8: Combinati: Product Portfolio
• Figure 10.9: Combinati: SWOT Analysis
• Figure 10.10: Dropworks, Inc.: Product Portfolio
• Figure 10.11: Fluidigm Corporation: Product Portfolio
• Figure 10.12: Fluidigm Corporation: Overall Financials, 2017-2019
• Figure 10.13: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
• Figure 10.14: Fluidigm Corporation.: Revenue (by Region), 2017-2019
• Figure 10.15: Fluidigm Corporation: R&D Expenditure, 2017-2019
• Figure 10.16: Fluidigm Corporation: SWOT Analysis
• Figure 10.17: Genetron Holdings Limited: Product Portfolio
• Figure 10.18: Genetron Holdings Limited: Overall Financials, 2017-2019
• Figure 10.19: Genetron Holdings Limited: Revenue (by Business Segment), 2017-2019
• Figure 10.20: Genetron Holdings Limited: R&D Expenditure (2017-2019)
• Figure 10.21: Genetron Holdings Limited: SWOT Analysis
• Figure 10.22: JN Medsys: Product Portfolio
• Figure 10.23 JN Medsys: SWOT Analysis
• Figure 10.24: Merck KGaA: Product Portfolio
• Figure 10.25: Merck KGaA: Overall Financials, 2017-2019
• Figure 10.26: Merck KGaA: Revenue (by Segment), 2017-2019
• Figure 10.27: Merck KGaA: Revenue (by Region), 2017-2019
• Figure 10.28: Merck KGaA: R&D Expenditure, 2017-2019
• Figure 10.29: Merck KGaA: SWOT Analysis
• Figure 10.30: Naveris, Inc.: Product Portfolio
• Figure 10.31: Naveris, Inc.: SWOT Analysis
• Figure 10.32: OPTOLANE Technologies Inc.: Product Portfolio
• Figure 10.33: OPTOLANE Technologies Inc.: SWOT Analysis
• Figure 10.34: QIAGEN N.V.: Product Offerings
• Figure 10.35: QIAGEN N.V.: Overall Financials, 2017-2019
• Figure 10.36: QIAGEN N.V.: Revenue (by Segment) $Million, 2017-2019
• Figure 10.37: QIAGEN N.V.: Revenue (by Region), 2017-2019
• Figure 10.38: QIAGEN N.V.: R&D Expenditure, 2017-2019
• Figure 10.39: QIAGEN N.V.: SWOT Analysis
• Figure 10.40: SAGA Diagnostics AB: Product Portfolio
• Figure 10.41: SAGA Diagnostics AB: SWOT Analysis
• Figure 10.42: Stem Genomics: Product Portfolio
• Figure 10.43: Stem Genomics: SWOT Analysis
• Figure 10.44: Sysmex Corporation: Overall Product Portfolio
• Figure 10.45: Sysmex Corporation: Overall Financials, 2017-2019
• Figure 10.46: Sysmex Corporation: Sales (by Segment), 2017-2019
• Figure 10.47: Sysmex Corporation: Sales (by Region), 2017-2019
• Figure 10.48: Sysmex Corporation: Research and Development Expenditure, 2017-2019
• Figure 10.49: Sysmex Corporation: SWOT Analysis
• Figure 10.50: Stilla Technologies Inc.: Product Portfolio
• Figure 10.51: Stilla Technologies Inc.: SWOT Analysis
• Figure 10.52: Thermo Fisher Scientific Inc.: Product Portfolio
• Figure 10.53: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
• Figure 10.54: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
• Figure 10.55: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
• Figure 10.56: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
• Figure 10.57: Thermo Fisher Scientific Inc.: SWOT Analysis